- Home
- NBBK vs SLP Comparison
NBBK vs SLP Comparison
Compare NBBK & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBBK
- SLP
- Stock Information
- Founded
- NBBK 1892
- SLP 1996
- Country
- NBBK United States
- SLP United States
- Employees
- NBBK N/A
- SLP N/A
- Industry
- NBBK
- SLP EDP Services
- Sector
- NBBK
- SLP Technology
- Exchange
- NBBK Nasdaq
- SLP Nasdaq
- Market Cap
- NBBK 687.7M
- SLP 675.9M
- IPO Year
- NBBK N/A
- SLP 1997
- Fundamental
- Price
- NBBK $18.76
- SLP $18.10
- Analyst Decision
- NBBK Buy
- SLP Buy
- Analyst Count
- NBBK 1
- SLP 7
- Target Price
- NBBK $22.00
- SLP $40.40
- AVG Volume (30 Days)
- NBBK 471.3K
- SLP 567.2K
- Earning Date
- NBBK 07-23-2025
- SLP 07-14-2025
- Dividend Yield
- NBBK N/A
- SLP 0.34%
- EPS Growth
- NBBK 421.39
- SLP N/A
- EPS
- NBBK 1.18
- SLP 0.36
- Revenue
- NBBK $169,131,000.00
- SLP $78,564,000.00
- Revenue This Year
- NBBK N/A
- SLP $27.66
- Revenue Next Year
- NBBK N/A
- SLP $6.75
- P/E Ratio
- NBBK $16.05
- SLP $49.29
- Revenue Growth
- NBBK 27.71
- SLP 21.49
- 52 Week Low
- NBBK $14.84
- SLP $16.72
- 52 Week High
- NBBK $21.05
- SLP $44.33
- Technical
- Relative Strength Index (RSI)
- NBBK 75.82
- SLP 29.53
- Support Level
- NBBK $17.70
- SLP $16.78
- Resistance Level
- NBBK $17.31
- SLP $18.95
- Average True Range (ATR)
- NBBK 0.47
- SLP 0.81
- MACD
- NBBK 0.27
- SLP 0.28
- Stochastic Oscillator
- NBBK 90.91
- SLP 45.86
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.